These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9824786)

  • 1. Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone.
    LeBel M; Masson E; Guilbert E; Colborn D; Paquet F; Allard S; Vallée F; Narang PK
    J Clin Pharmacol; 1998 Nov; 38(11):1042-50. PubMed ID: 9824786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive.
    Yu Z; Yu D; Walker PS; Tang-Liu DD
    Clin Pharmacokinet; 2004; 43(10):673-84. PubMed ID: 15244497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
    Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
    Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE; Doose DR; Walker SA; Nayak RK
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
    Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR
    Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers.
    Inglis AM; Miller AK; Culkin KT; Finnerty D; Patterson SD; Jorkasky DK; Freed MI
    J Clin Pharmacol; 2001 Jun; 41(6):683-90. PubMed ID: 11402638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
    Sinofsky FE; Pasquale SA
    Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D; Smith S; Zacur H
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteers.
    Crauwels HM; van Heeswijk RP; Buelens A; Stevens M; Hoetelmans RM
    Int J Clin Pharmacol Ther; 2014 Feb; 52(2):118-28. PubMed ID: 24161160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone.
    Lin WH; Feng HP; Shadle CR; O'Reilly T; Wagner JA; Butterton JR
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1107-13. PubMed ID: 24992979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR; Colburn W; Kook KA; Thomas SD
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
    Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ
    Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of steady-state ambrisentan on the pharmacokinetics of a single dose of the oral contraceptive norethindrone (norethisterone) 1 mg/ethinylestradiol 35 microg in healthy subjects: an open-label, single-sequence, single-centre study.
    Spence R; Mandagere A; Walker G; Dufton C; Boinpally R
    Clin Drug Investig; 2010; 30(5):313-24. PubMed ID: 20384387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.